BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS

GenScript ProBio extended congratulations on this. Since December 2019, GenScript ProBio has joined the strategic collaboration with Selecxine for the...

December 07, 2022 | News

WuXi AppTec Begins Construction of Wuxi STA Pharmaceutical East China R&D Facility

WuXi AppTec recently held the groundbreaking ceremony for its Wuxi STA Pharmaceutical East China R&D facility in tandem with the signing ceremony...

November 24, 2022 | News

Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its cell therapy contract development and manufacturing (C...

November 08, 2022 | News

I Peace partners with the California Institute for Regenerative Medicine [CIRM]

I Peace has been providing GMP Induced Pluripotent Stem Cells (iPSC) for a variety of cell therapy developers and pharmaceutical companies in the pas...

November 02, 2022 | News

Polyplus and ENcell sign MOU for gene therapy discovery and optimization projects in Korea

“ENCell is working to accelerate viral vector CMO business via a collaboration with Polyplus.”, said Dr. Jong Wook Chang, CEO of ENCell. &ldquo...

October 28, 2022 | News

New Fully Automated Vetter Warehouse Expands Storage and Boosts Logistical Infrastructure

Vetter, a globally leading contract development and manufacturing organization (CDMO), announced the commissioning of a new warehouse designed to help meet...

October 28, 2022 | News

Emmes (Global CRO) rapidly expands in India

Global CRO’s India office reports surging growth from Western, regional and local trial customers Emmes – a global, full-se...

October 28, 2022 | News

WuXi Biologics Announces GMP Release of 48,000L Commercial Drug Substance Manufacturing Facility in Hebei, China

The facility's design incorporates environmental protection, energy conservation, emission reduction, and resource utilization – a reflection of WuXi...

October 26, 2022 | News

WuXi Biologics adds further capacity and capability for drug product fill & finish

WuXi Biologics to provide global customers with end-to-end integrated solutions for diversified modalities, including mRNA-LNP. WuXi Biologics ("WuXi Bio"...

October 24, 2022 | News

GenScript ProBio Signs MOU to Form Strategic Partnership with GeneCraft

GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and GeneCraft (Suk Chul Bae, CEO), a global research team led by Professor Suk Ch...

October 18, 2022 | News

Samsung Biologics obtains three global ISO certifications

Receives accreditation for information security management system, information security in cloud services, and anti-bribery management systems F...

October 14, 2022 | News

Samsung Biologics unlocks additional capacity for production at its newest Plant 4

Plant 4 commences GMP operations within just 23 months since groundbreaking, as planned Partial operations add fresh biomanufacturing capacity of 60,000...

October 12, 2022 | News

WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody

Within the partnership, Toregem BioPharma will have access to WuXi Biologics' integrated CMC services in cell line development, cell banking and testing se...

October 12, 2022 | News

Vetter drives its sustainability campaign forward

Repeat participation in Baden Wuerttemberg’s Sustainability Days Greater inclusion of employees due to involvement in various initiatives Awards ...

October 11, 2022 | News

Stay Connected